Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial.

Gilbert A, Adams R, Webster J, Gilbert DC, Abbott NL, Berkman L, Bottomley D, Brown SR, Casanova N, Copeland J, Falk S, Glynne-Jones R, Goh V, Hawkins MA, Khan S, Muirhead R, Rao S, Renehan AG, Richman SD, Ruddock S, Smith A, Stewart AJ, Whibley M, Wood HM, Sebag-Montefiore D, Harrison M, PLATO trial study group

Open source

DOI: 10.1016/s1470-2045(25)00213-x
Published: 2025 Jun
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-25-00213-x,
  title = {Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial.},
  author = {Gilbert A and Adams R and Webster J and Gilbert DC and Abbott NL and Berkman L and Bottomley D and Brown SR and Casanova N and Copeland J and Falk S and Glynne-Jones R and Goh V and Hawkins MA and Khan S and Muirhead R and Rao S and Renehan AG and Richman SD and Ruddock S and Smith A and Stewart AJ and Whibley M and Wood HM and Sebag-Montefiore D and Harrison M and PLATO trial study group},
  year = {2025},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(25)00213-x},
  url = {https://doi.org/10.1016/s1470-2045(25)00213-x}
}

RIS

TY  - JOUR
TI  - Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial.
AU  - Gilbert A
AU  - Adams R
AU  - Webster J
AU  - Gilbert DC
AU  - Abbott NL
AU  - Berkman L
AU  - Bottomley D
AU  - Brown SR
AU  - Casanova N
AU  - Copeland J
AU  - Falk S
AU  - Glynne-Jones R
AU  - Goh V
AU  - Hawkins MA
AU  - Khan S
AU  - Muirhead R
AU  - Rao S
AU  - Renehan AG
AU  - Richman SD
AU  - Ruddock S
AU  - Smith A
AU  - Stewart AJ
AU  - Whibley M
AU  - Wood HM
AU  - Sebag-Montefiore D
AU  - Harrison M
AU  - PLATO trial study group
PY  - 2025
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(25)00213-x
UR  - https://doi.org/10.1016/s1470-2045(25)00213-x
ER  -

APA

A, G., R, A., J, W., DC, G., NL, A., L, B., D, B., SR, B., N, C., J, C., S, F., R, G., V, G., MA, H., S, K., R, M., S, R., AG, R., SD, R., S, R., A, S., AJ, S., M, W., HM, W., D, S., M, H., & group, P. T. S. (2025). Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(25)00213-x

Source records

pubmed · retrieved 2026-09-27T11:52:34.177Z
europe-pmc · retrieved 2026-09-27T11:52:34.189Z